Description

Beyfortus is a monoclonal antibody used for the prevention of respiratory syncytial virus (RSV) in infants and young children. It provides passive immunity by targeting the virus, helping to reduce the risk of severe RSV disease.

Interpreter Notes

Interpreters should be aware that Beyfortus may be referred to in various ways in clinical settings, but it is essential to use the term 'Beyfortus' for clarity. Avoid colloquial terms or regional variations that might confuse patients or healthcare providers. Ensure that the context of use is clear, particularly when discussing preventive measures against RSV.

Example Sentences

EN: The pediatrician recommended Beyfortus for the infant to help prevent severe RSV infection.

ES: El pediatra recomendó Beyfortus para el infante para ayudar a prevenir infecciones severas por RSV.

Common Interpreter Mistakes

Confusing Beyfortus with other RSV treatments; mispronouncing 'Beyfortus' leading to misunderstandings; using informal terms instead of the clinical term.